Vorinostat Approved in Japan for Treatment of Cutaneous T-Cell Lymphomas: Status and Prospects

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s23874
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited